TY - JOUR
T1 - Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue
AU - Harwood, Dylan Scott Lykke
AU - Pedersen, Vilde
AU - Bager, Nicolai Schou
AU - Schmidt, Ane Yde
AU - Stannius, Tobias Overlund
AU - Areškevičiūtė, Aušrinė
AU - Josefsen, Knud
AU - Nørøxe, Dorte Schou
AU - Scheie, David
AU - Rostalski, Hannah
AU - Lü, Maya Jeje Schuang
AU - Locallo, Alessio
AU - Lassen, Ulrik
AU - Bagger, Frederik Otzen
AU - Weischenfeldt, Joachim
AU - Heiland, Dieter Henrik
AU - Vitting-Seerup, Kristoffer
AU - Michaelsen, Signe Regner
AU - Kristensen, Bjarne Winther
N1 - © 2024. The Author(s).
PY - 2024/9/9
Y1 - 2024/9/9
N2 - Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the surrounding healthy brain tissue, where they give rise to the recurrent tumor. Based on gene expression, tumor cores can be subtyped into mesenchymal, proneural, and classical tumors, each being associated with differences in genetic alterations and cellular composition. In contrast, the adjacent brain parenchyma where infiltrating malignant cells escape surgical resection is less characterized in patients. Using spatial transcriptomics (n = 11), we show that malignant cells within proneural or mesenchymal tumor cores display spatially organized differences in gene expression, although such differences decrease within the infiltrated brain tissue. Malignant cells residing in infiltrated brain tissue have increased expression of genes related to neurodevelopmental pathways and glial cell differentiation. Our findings provide an updated view of the spatial landscape of glioblastomas and further our understanding of the malignant cells that infiltrate the healthy brain, providing new avenues for the targeted therapy of these cells after surgical resection.
AB - Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the surrounding healthy brain tissue, where they give rise to the recurrent tumor. Based on gene expression, tumor cores can be subtyped into mesenchymal, proneural, and classical tumors, each being associated with differences in genetic alterations and cellular composition. In contrast, the adjacent brain parenchyma where infiltrating malignant cells escape surgical resection is less characterized in patients. Using spatial transcriptomics (n = 11), we show that malignant cells within proneural or mesenchymal tumor cores display spatially organized differences in gene expression, although such differences decrease within the infiltrated brain tissue. Malignant cells residing in infiltrated brain tissue have increased expression of genes related to neurodevelopmental pathways and glial cell differentiation. Our findings provide an updated view of the spatial landscape of glioblastomas and further our understanding of the malignant cells that infiltrate the healthy brain, providing new avenues for the targeted therapy of these cells after surgical resection.
KW - Humans
KW - Glioblastoma/genetics
KW - Brain Neoplasms/genetics
KW - Signal Transduction
KW - Receptors, Notch/metabolism
KW - Brain/metabolism
KW - Gene Expression Regulation, Neoplastic
KW - Transcriptome
KW - Synapses/metabolism
KW - Male
KW - Female
KW - Cell Line, Tumor
KW - Neuroglia/metabolism
KW - Cell Differentiation/genetics
UR - http://www.scopus.com/inward/record.url?scp=85203345816&partnerID=8YFLogxK
M3 - Journal article
C2 - 39251578
SN - 2041-1722
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 7857
ER -